Standout Papers

Industry sponsorship and research outcome 2012 2026 2016 2021 1.2k
  1. Industry sponsorship and research outcome (2012)
    Andreas Lundh, Sergio Sismondo et al. Cochrane Database of Systematic Reviews
  2. Industry sponsorship and research outcome (2017)
    Andreas Lundh, Joel Lexchin et al. Cochrane Database of Systematic Reviews

Citation Impact

Citing Papers

Oral diseases: a global public health challenge
2019 Standout
SYRCLE’s risk of bias tool for animal studies
2014 Standout
Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder
2016
Major depressive disorder
2016 Standout
Development quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists
2010
Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes
2018 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
2020 Standout
Effects of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation: A Meta-analysis
2013
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
2012 Standout
A proposed method of bias adjustment for meta-analyses of published observational studies
2010
The abundance and variety of carbohydrate-active enzymes in the human gut microbiota
2013 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts
2017 Standout
Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research
2010
Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis
2016 Standout
Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports
2016
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Human Gut Microbiota: Repertoire and Variations
2012
Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study
2016
The Effect of Physical Activity Interventions on Children’s Cognition and Metacognition: A Systematic Review and Meta-Analysis
2017 Standout
Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)
2017
Gout
2016 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?
2013
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
Age-related macular degeneration
2018 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Evaluating the environmental hazard of industrial chemicals from data collected during the REACH registration process
2017
Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration
2014
Systematic reviews synthesized evidence without consistent quality assessment of primary studies examining epidemiology of chronic diseases
2012
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
2012
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration
2021
Weight gain by gut microbiota manipulation in productive animals
2016
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
2012 Standout
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement
2021 Standout
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients
2013
Should people at low risk of cardiovascular disease take a statin?
2013
Public Availability of Published Research Data in High-Impact Journals
2011
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
2020 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Irritable Bowel Syndrome
2015 Standout
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Non-steroidal anti-inflammatory drugs for acute gout
2014
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
The Navigation Guide Systematic Review Methodology: A Rigorous and Transparent Method for Translating Environmental Health Science into Better Health Outcomes
2014
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
2013
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus
2017
Toward a Global Understanding of Chemical Pollution: A First Comprehensive Analysis of National and Regional Chemical Inventories
2020 Standout
A selection model for accounting for publication bias in a full network meta‐analysis
2014
The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Integration of Animal and Human Evidence for PFOA Effects on Fetal Growth
2014
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
2021 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
2016
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review
2013
Neuraminidase inhibitors for preventing and treating influenza in adults and children
2014
Systematic review of compression following treatment for varicose veins
2015 StandoutNobel
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma
2013
The preregistration revolution
2018 Standout
The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review
2018
Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health
2019
Cannabinoids for Medical Use
2015 Standout
Surgery for weight loss in adults
2014 Standout
Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review
2013
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Nonhuman Evidence for PFOA Effects on Fetal Growth
2014
Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine
2020 Standout
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
External beam radiotherapy for unresectable hepatocellular carcinoma
2017
Management of people with early- or very early-stage hepatocellular carcinoma
2017
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout

Works of Andreas Lundh being referenced

Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications
2014
Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study
2013
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
2008
Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study
2010
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses
2012
Industry sponsorship and research outcome: systematic review with meta-analysis
2018
Industry sponsorship and research outcome
2012 Standout
Industry sponsorship and research outcome
2017 Standout
Rankless by CCL
2026